CorMedix Stock (NASDAQ:CRMD)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$12.04

52W Range

$2.57 - $13.85

50D Avg

$9.10

200D Avg

$5.66

Market Cap

$708.10M

Avg Vol (3M)

$1.18M

Beta

1.58

Div Yield

-

CRMD Company Profile


CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as hemodialysis, total parenteral nutrition, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

82

IPO Date

May 13, 2010

Website

CRMD Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 21Dec 20
Europe$190.94K$237.03K

Fiscal year ends in Dec 23 | Currency in USD

CRMD Financial Summary


Dec 23Dec 22Dec 21
Revenue-$65.41K$190.94K
Operating Income$-48.96M$-30.62M$-29.44M
Net Income$-46.34M$-29.70M$-28.21M
EBITDA$-48.75M$-30.30M$-29.44M
Basic EPS$-0.91$-0.74$-0.75
Diluted EPS$-0.91$-0.74$-0.75

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts


Q3 24Oct 30, 24 | 12:32 PM
Q2 24Aug 14, 24 | 2:08 PM
Q1 24May 09, 24 | 12:00 AM

Peer Comparison


TickerCompany
NUVBNuvation Bio Inc.
GOSSGossamer Bio, Inc.
ALDXAldeyra Therapeutics, Inc.
TVTXTravere Therapeutics, Inc.
INBXInhibrx Biosciences, Inc.
REPLReplimune Group, Inc.
APTOAptose Biosciences Inc.
LIANLianBio
ETONEton Pharmaceuticals, Inc.
SGMOSangamo Therapeutics, Inc.
CNTBConnect Biopharma Holdings Limited
KRONKronos Bio, Inc.
ELDNEledon Pharmaceuticals, Inc.
ABOSAcumen Pharmaceuticals, Inc.
PGENPrecigen, Inc.
TARSTarsus Pharmaceuticals, Inc.
LYRALyra Therapeutics, Inc.
CELCCelcuity Inc.
MACKMerrimack Pharmaceuticals, Inc.
NVCTNuvectis Pharma, Inc.
ELVNEnliven Therapeutics, Inc.
ELYMEliem Therapeutics, Inc.